1
|
Emtestam L, Lapins J, Sartorius K. A growing family of outcome measurement proposals for hidradenitis suppurativa. Br J Dermatol 2021; 184:796-798. [PMID: 33398878 PMCID: PMC8247045 DOI: 10.1111/bjd.19712] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2020] [Accepted: 11/19/2020] [Indexed: 11/28/2022]
Abstract
Linked Article: Goldfarb et al. Br J Dermatol 2021; 184:905–912.
Collapse
Affiliation(s)
- L Emtestam
- Department of Medicine, Karolinska University Hospital, Stockholm, Sweden
| | - J Lapins
- Department of Dermatology, Karolinska University Hospital, Stockholm, Sweden
| | - K Sartorius
- Department of Dermatology, South General Hospital, Stockholm, Sweden
| |
Collapse
|
2
|
Thorlacius L, Garg A, Riis P, Nielsen S, Bettoli V, Ingram J, Marmol V, Matusiak L, Pascual J, Revuz J, Sartorius K, Tzellos T, Zee H, Zouboulis C, Saunte D, Gottlieb A, Christensen R, Jemec G. 化脓性汗腺炎量表的评定者间可靠性和一致性. Br J Dermatol 2019. [DOI: 10.1111/bjd.18282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
3
|
Thorlacius L, Garg A, Riis P, Nielsen S, Bettoli V, Ingram J, Marmol V, Matusiak L, Pascual J, Revuz J, Sartorius K, Tzellos T, Zee H, Zouboulis C, Saunte D, Gottlieb A, Christensen R, Jemec G. Inter‐rater reliability and agreement hidradenitis suppurativa instruments. Br J Dermatol 2019. [DOI: 10.1111/bjd.18268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
4
|
Thorlacius L, Garg A, Riis P, Nielsen S, Bettoli V, Ingram J, Marmol V, Matusiak L, Pascual J, Revuz J, Sartorius K, Tzellos T, Zee H, Zouboulis C, Saunte D, Gottlieb A, Christensen R, Jemec G. Inter‐rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa. Br J Dermatol 2019; 181:483-491. [DOI: 10.1111/bjd.17716] [Citation(s) in RCA: 37] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/31/2019] [Indexed: 12/30/2022]
Affiliation(s)
- L. Thorlacius
- Department of Dermatology Zealand University Hospital Roskilde/Health Sciences Faculty, University of Copenhagen Copenhagen Denmark
- Musculoskeletal Statistics Unit The Parker Institute, Bispebjerg and Frederiksberg Hospital The Capital Region of Denmark Copenhagen Denmark
| | - A. Garg
- Department of Dermatology Zucker School of Medicine at Hofstra/Northwell Hempstead NY U.S.A
| | - P.T. Riis
- Department of Dermatology Zealand University Hospital Roskilde/Health Sciences Faculty, University of Copenhagen Copenhagen Denmark
| | - S.M. Nielsen
- Musculoskeletal Statistics Unit The Parker Institute, Bispebjerg and Frederiksberg Hospital The Capital Region of Denmark Copenhagen Denmark
| | - V. Bettoli
- Dermatology and Venereology University of Ferrara Ferrara Italy
| | - J.R. Ingram
- Department of Dermatology & Academic Wound Healing Cardiff University Cardiff U.K
| | - V. Marmol
- Department of Dermatology Hopital Erasme, Brussels, Université Libre de Bruxelles Brussels Belgium
| | - L. Matusiak
- Department of Dermatology, Venereology and Allergology Medical University Wrocław Poland
| | - J.C. Pascual
- Department of Dermatology Hospital General Universitario de Alicante Alicante Spain
| | - J. Revuz
- 11 chaussée de la muette 75016 Paris France
| | - K. Sartorius
- Department of Dermatology Stockholm South General Hospital (Södersjukhuset) Stockholm Sweden
- Department of Clinical Science and Education Karolinska Institutet Stockholm Sweden
| | - T. Tzellos
- Department of Dermatology Faculty of Health Sciences University Hospital of North Norway Tromso Norway
| | - H.H. Zee
- Department of Dermatology Erasmus University Medical Center Rotterdam the Netherlands
| | - C.C. Zouboulis
- Departments of Dermatology, Venereology, Allergology and Immunology Dessau Medical Center Brandenburg Medical School Theodor Fontane Dessau Germany
| | - D.M. Saunte
- Department of Dermatology Zealand University Hospital Roskilde/Health Sciences Faculty, University of Copenhagen Copenhagen Denmark
| | - A.B. Gottlieb
- Department of Dermatology ICahn School of Medicine at Mount Sinai New York NY U.S.A
| | - R. Christensen
- Musculoskeletal Statistics Unit The Parker Institute, Bispebjerg and Frederiksberg Hospital The Capital Region of Denmark Copenhagen Denmark
- Department of Rheumatology Odense University Hospital Odense Denmark
| | - G.B.E. Jemec
- Department of Dermatology Zealand University Hospital Roskilde/Health Sciences Faculty, University of Copenhagen Copenhagen Denmark
| |
Collapse
|
5
|
Affiliation(s)
- L Emtestam
- Department of Dermatology, Karolinska University Hospital, Stockholm, Sweden
| | - K Sartorius
- Department of Dermatology, South General Hospital, Stockholm, Sweden
| |
Collapse
|
6
|
Sartorius B, Sartorius K, Taylor M, Aagaard-Hansen J, Dukhi N, Day C, Ndlovu N, Slotow R, Hofman K. Rapidly increasing body mass index among children, adolescents and young adults in a transitioning population, South Africa, 2008-15. Int J Epidemiol 2018; 47:2099. [PMID: 30376046 PMCID: PMC6280934 DOI: 10.1093/ije/dyy248] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022] Open
|
7
|
Sartorius B, Sartorius K, Taylor M, Aagaard-Hansen J, Dukhi N, Day C, Ndlovu N, Slotow R, Hofman K. Rapidly increasing body mass index among children, adolescents and young adults in a transitioning population, South Africa, 2008-15. Int J Epidemiol 2018; 47:942-952. [PMID: 29253189 PMCID: PMC6005035 DOI: 10.1093/ije/dyx263] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Revised: 11/21/2017] [Accepted: 12/04/2017] [Indexed: 11/18/2022] Open
Abstract
Background There is a global epidemic of overweight and obesity; however, this rate of increase is even greater in some low- and middle-income countries (LMIC). South Africa (SA) is undergoing rapid socioeconomic and demographic changes that have triggered a rapid nutrition transition. The paper focuses on the recent rate of change of body mass index (BMI) among children, adolescents and young adults, further stratified by key sociodemographic factors. Methods We analysed mean BMI of 28 247 individuals (including children) from 7301 households by age and year, from anthropometric data from four national cross-sectional (repeated panel) surveys using non-linear fitted curves and associated 95% confidence intervals. Results From 2008 to 2015, there was rapid rise in mean BMI in the 6-25 age band, with the highest risk (3-4+ BMI unit increase) among children aged 8-10 years. The increase was largely among females in urban areas and of middle-high socioeconomic standing. Prominent gains were also observed in certain rural areas, with extensive geographical heterogeneity across the country. Conclusions We have demonstrated a major deviation from the current understanding of patterns of BMI increase, with a rate of increase substantially greater in the developing world context compared with the global pattern. This population-wide effect will have major consequences for national development as the epidemic of related non-communicable disease unfolds, and will overtax the national health care budget. Our refined understanding highlights that risks are further compounded for certain groups/places, and emphasizes that urgent geographical and population-targeted interventions are necessary. These interventions could include a sugar tax, clearer food labelling, revised school feeding programmes and mandatory bans on unhealthy food marketing to children.The scenario unfolding in South Africa will likely be followed in other LMICs.
Collapse
Affiliation(s)
- B Sartorius
- Public Health Medicine, University of KwaZulu-Natal, Durban, South Africa
| | - K Sartorius
- Public Health Medicine, University of KwaZulu-Natal, Durban, South Africa
- Faculty of Commerce, University of the Witwatersrand, Johannesburg, South Africa
| | - M Taylor
- Public Health Medicine, University of KwaZulu-Natal, Durban, South Africa
| | - J Aagaard-Hansen
- Steno Diabetes Center Copenhagen, Gentofte, Denmark, and MRC Developmental Pathways for Health Research Unit, University of the Witwatersrand, Johannesburg, South Africa
| | - N Dukhi
- Public Health Medicine, University of KwaZulu-Natal, Durban, South Africa
| | - C Day
- Health Systems Trust, Westville, South Africa
| | - N Ndlovu
- Health Systems Trust, Westville, South Africa
| | - R Slotow
- School of Life Sciences, University of KwaZulu-Natal, Durban, South Africa
- Department of Genetics, Evolution and Environment, University College London, London, UK
| | - K Hofman
- School of Public Health, University of the Witwatersrand, Johannesburg, South Africa
| |
Collapse
|
8
|
Sartorius K, Sartorius B, Kramvis A, Singh E, Turchinovich A, Burwinkel B, Madiba T, Winkler CA. Circulating microRNA's as a diagnostic tool for hepatocellular carcinoma in a hyper endemic HIV setting, KwaZulu-Natal, South Africa: a case control study protocol focusing on viral etiology. BMC Cancer 2017; 17:894. [PMID: 29282036 PMCID: PMC5745691 DOI: 10.1186/s12885-017-3915-z] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2016] [Accepted: 12/14/2017] [Indexed: 12/15/2022] Open
Abstract
Background A wide range of studies has investigated the diagnostic proficiency of extracellular microRNAs (miRNAs) in hepatocellular cancer (HCC). HCC is expected to increase in Sub-Saharan Africa (SSA), due to endemic levels of viral infection (HBV/HIV), ageing and changing lifestyles. This unique aetiological background provides an opportunity for investigating potentially novel circulating miRNAs as biomarkers for HCC in a prospective study in South Africa. Methods This study will recruit HCC patients from two South African cancer hospitals, situated in Durban and Pietermaritzburg in the province of KwaZulu-Natal. These cases will include both HBV mono-infected and HBV/HIV co-infected HCC cases. The control group will consist of two (2) age and sex-matched healthy population controls per HCC case randomly selected from a Durban based laboratory. The controls will exclude patients if they have any evidence of chronic liver disease. A standardised reporting approach will be adopted to detect, quantify and normalize the level of circulating miRNAs in the blood sera of HCC cases and their controls. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) will be employed to quantity extracellular miRNAs. Differences in concentration of relevant miRNA by case/control status will be assessed using the Wilcoxon rank-sum (Mann-Whitney U) test. Adjustment for multiple testing (Bonferroni correction), receiver operating curves (ROC) and optimal breakpoint analyses will be employed to identify potential thresholds for the differentiation of miRNA levels of HCC cases and their controls. Discussion Although there is a growing base of literature regarding the role of circulating miRNAs as biomarkers, this promising field remains a ‘work in progress’. The aetiology of HBV infection in HCC is well understood, as well as it’s role in miRNA deregulation, however, the mediating role of HIV infection is unknown. HCC incidence in SSA, including South Africa, is expected to increase significantly in the next decade. A combination of factors, therefore, offers a unique opportunity to identify candidate circulating miRNAs as potential biomarkers for HBV/HIV infected HCC. Electronic supplementary material The online version of this article (10.1186/s12885-017-3915-z) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- K Sartorius
- Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, 4041, South Africa.,Faculty of Commerce, Law and Management, University of the Witwatersrand, Johannesburg, South Africa.,UKZN Gastrointestinal Cancer Research Centre (GICRC), Durban, South Africa
| | - B Sartorius
- Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, 4041, South Africa. .,UKZN Gastrointestinal Cancer Research Centre (GICRC), Durban, South Africa.
| | - A Kramvis
- Hepatitis Virus Diversity Research Unit, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Parktown, Johannesburg, South Africa
| | - E Singh
- South African National Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa
| | - A Turchinovich
- Molecular Epidemiology Group, German Cancer Research Centre, Heidelberg, Germany.,SciBerg e.Kfm, Mannheim, Germany
| | - B Burwinkel
- Molecular Epidemiology Group, German Cancer Research Centre, Heidelberg, Germany
| | - T Madiba
- UKZN Gastrointestinal Cancer Research Centre (GICRC), Durban, South Africa
| | - C A Winkler
- Basic Research Laboratory, Centre for Cancer Research, National Cancer Institute, Leidos Biomedical Research, Inc. Frederick Nat. Lab. for Cancer Research, Frederick, MD, USA
| |
Collapse
|
9
|
Affiliation(s)
- L. Emtestam
- Department of Dermatology Karolinska University Hospital Stockholm Sweden
| | - K. Sartorius
- Department of Dermatology South General Hospital Stockholm Sweden
| |
Collapse
|
10
|
Sartorius B, Sartorius K, Aldous C, Madiba TE, Stefan C, Noakes T. Carbohydrate intake, obesity, metabolic syndrome and cancer risk? A two-part systematic review and meta-analysis protocol to estimate attributability. BMJ Open 2016; 6:e009301. [PMID: 26729382 PMCID: PMC4716256 DOI: 10.1136/bmjopen-2015-009301] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
INTRODUCTION Linkages between carbohydrates, obesity and cancer continue to demonstrate conflicting results. Evidence suggests inconclusive direct linkages between carbohydrates and specific cancers. Conversely, obesity has been strongly linked to a wide range of cancers. The purpose of the study is to explore linkages between carbohydrate intake and cancer types using a two-step approach. First the study will evaluate the linkages between carbohydrate intake and obesity, potentially stratified by metabolic syndrome status. Second, the estimated attributable fraction of obesity ascribed to carbohydrate intake will be multiplied against obesity attributable fractions for cancer types to give estimated overall attributable fraction for carbohydrate versus cancer type. METHODS AND ANALYSIS We will perform a comprehensive search to identify all possible published and unpublished studies that have assessed risk factors for obesity including dietary carbohydrate intake. Scientific databases, namely PubMed MEDLINE, EMBASE, EBSCOhost and ISI Web of Science will be searched. Following study selection, paper/data acquisition, and data extraction and synthesis, we will appraise the quality of studies and risk of bias, as well as assess heterogeneity. Meta-weighted attributable fractions of obesity due to carbohydrate intake will be estimated after adjusting for other potential confounding factors (eg, physical inactivity, other dietary intake). Furthermore, previously published systematic reviews assessing the cancer-specific risk associated with obesity will also be drawn. These estimates will be linked with the attributability of carbohydrate intake in part 1 to estimate the cancer-specific burden that can be attributed to dietary carbohydrates. This systematic review protocol has been developed according to the 'Preferred Reporting Items for Systematic review and Meta-Analysis Protocols (PRISMA-P) 2015'. ETHICS AND DISSEMINATION The current study will be based on published literature and data, and, as such, ethics approval is not required. The final results of this two part systematic review (plus multiplicative calculations) will be published in a relevant international peer-reviewed journal. TRIAL REGISTRATION NUMBER PROSPERO CRD42015023257.
Collapse
Affiliation(s)
- B Sartorius
- Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa
- University of KwaZulu-Natal Gastrointestinal Cancer Research Centre (GICRC), Durban, KwaZulu-Natal, South Africa
| | - K Sartorius
- Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa
- University of KwaZulu-Natal Gastrointestinal Cancer Research Centre (GICRC), Durban, KwaZulu-Natal, South Africa
- Faculty of Commerce, University of the Witwatersrand, Johannesburg, South Africa
| | - C Aldous
- University of KwaZulu-Natal Gastrointestinal Cancer Research Centre (GICRC), Durban, KwaZulu-Natal, South Africa
- School of Clinical Medicine, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa
| | - T E Madiba
- University of KwaZulu-Natal Gastrointestinal Cancer Research Centre (GICRC), Durban, KwaZulu-Natal, South Africa
- School of Clinical Medicine, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa
| | - C Stefan
- University of KwaZulu-Natal Gastrointestinal Cancer Research Centre (GICRC), Durban, KwaZulu-Natal, South Africa
- South African Medical Research Council, Cape Town, South Africa
| | - T Noakes
- Division of Exercise Science and Sports Medicine, University of Cape Town
| |
Collapse
|
11
|
Saunte D, Boer J, Stratigos A, Szepietowski J, Hamzavi I, Kim K, Zarchi K, Antoniou C, Matusiak L, Lim H, Williams M, Kwon H, Gürer M, Mammadova F, Kaminsky A, Prens E, van der Zee H, Bettoli V, Zauli S, Hafner J, Lauchli S, French L, Riad H, El-Domyati M, Abdel-Wahab H, Kirby B, Kelly G, Calderon P, del Marmol V, Benhadou F, Revuz J, Zouboulis C, Karagiannidis I, Sartorius K, Hagströmer L, McMeniman E, Ong N, Dolenc-Voljc M, Mokos Z, Borradori L, Hunger R, Sladden C, Scheinfeld N, Moftah N, Emtestam L, Lapins J, Doss N, Kurokawa I, Jemec G. Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol 2015. [DOI: 10.1111/bjd.14038] [Citation(s) in RCA: 183] [Impact Index Per Article: 20.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
12
|
Sartorius K, Killasli H, Oprica C, Sullivan A, Lapins J. Bacteriology of hidradenitis suppurativa exacerbations and deep tissue cultures obtained during carbon dioxide laser treatment. Br J Dermatol 2012; 166:879-83. [PMID: 22098253 DOI: 10.1111/j.1365-2133.2011.10747.x] [Citation(s) in RCA: 64] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
BACKGROUND Previous studies have shown different bacteria in hidradenitis suppurativa (HS) lesions, but the literature regarding bacteria in acute exacerbation of HS is sparse. OBJECTIVES To determine the type of bacteria isolated from HS lesions during exacerbations of the disease. METHODS Patients with HS with acute nodules or abscesses were examined and treated by carbon dioxide laser vaporization. Bacterial samples for aerobic and anaerobic cultures were taken from the skin surface (before surgery) and then from the deeper layers (during surgery) of the lesions. At each level two samples were taken, one with a punch biopsy and one by pressing a soft agar gel against the skin. The bacterial findings were typed and quantified. RESULTS A total of 10 patients (eight women and two men), with a mean age of 37·2 years and a mean HS duration of 14·5 years, were included. All of them had an ongoing exacerbation (mean duration 5·6 days) of their HS, with one inflamed lesion that was treated by carbon dioxide laser vaporization. Coagulase-negative staphylococci (CNS) were found in the deep layers in all 10 patients. Nine of the patients carried Corynebacterium spp. and two alpha-haemolytic streptococci at various levels. Among the anaerobic microorganisms, Gram-positive cocci were the most common bacteria. CONCLUSIONS As found in a previous study, CNS were the most common bacteria, but contrary to what we expected, Staphylococcus aureus was not found in any cultures from acute inflammatory nodules of HS exacerbations.
Collapse
Affiliation(s)
- K Sartorius
- Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, SE-118 83 Stockholm, Sweden.
| | | | | | | | | |
Collapse
|
13
|
Sartorius K, Killasli H, Heilborn J, Jemec G, Lapins J, Emtestam L. Interobserver variability of clinical scores in hidradenitis suppurativa is low. Br J Dermatol 2010; 162:1261-8. [DOI: 10.1111/j.1365-2133.2010.09715.x] [Citation(s) in RCA: 52] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
14
|
Abstract
BACKGROUND Hidradenitis suppurativa (HS) is a long-standing disease with abscess and often fistula formation, predominantly in the axillae and groins. The disease is difficult to treat and has a severe impact on quality of life. A clinically relevant system for scoring disease severity is lacking in HS. OBJECTIVES To evaluate the modified Hidradenitis Suppurativa Score (HSS) and to study the impact of body mass index (BMI) and smoking habits on disease severity. METHODS Two hundred and fifty-one consecutive patients with HS referred to a clinic with special interest in the disease were included, of whom 115 were scored. Points were given for regions involved, types of lesion (nodules, fistulas), total area involved and whether lesions were separated by normal skin. Background characteristics included BMI and smoking habits. Two hundred and forty-six patients completed the Dermatology Life Quality Index (DLQI). RESULTS The median (interquartile range, IQR) HSS for all patients was 38 (18-66): women 38 (18-71) and men 37 (19-51). Median (IQR) HSS for smokers was 41 (22-75.5), former smokers 27 (16-53) and nonsmokers 22 (10-57). Median (IQR) HSS for patients with BMI < 25 kg m(-2) was 32 (12-54), BMI 25-30 kg m(-2) 44 (22-56) and BMI > or = 30 kg m(-2) 50 (18-86). Mean +/- SD DLQI for the whole group of patients was 10.3 +/- 7.5, median 9, and showed no significant differences between the groups studied. There was a significant positive correlation of fair degree between HSS and DLQI. There were significant differences in HSS between nonsmokers and smokers as well as between women of normal weight compared with obese women. CONCLUSIONS The modified HSS is simple and practical and it extracts important clinical information. A connection between disease severity and BMI as well as smoking habits in patients with HS is presented. The results suggest that the HSS may be a relevant outcome measure in future therapeutic trials in HS.
Collapse
Affiliation(s)
- K Sartorius
- Section of Dermatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86 Stockholm, Sweden.
| | | | | | | |
Collapse
|
15
|
Kurzen H, Kurokawa I, Jemec GBE, Emtestam L, Sellheyer K, Giamarellos-Bourboulis EJ, Nagy I, Bechara FG, Sartorius K, Lapins J, Krahl D, Altmeyer P, Revuz J, Zouboulis CC. What causes hidradenitis suppurativa? Exp Dermatol 2008; 17:455-6; discussion 457-72. [PMID: 18400064 DOI: 10.1111/j.1600-0625.2008.00712_1.x] [Citation(s) in RCA: 157] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Hidradenitis suppurativa (HS)--a rather common, very chronic and debilitating inflammatory skin appendage disorder with a notoriously underestimated burden of disease--has long been a playground for the high priests of nomenclature: Ask a bunch of eminent dermatologists and skin pathologists to publicly share their thoughts on what causes HS, and they will soon get entrenched in a heated debate on whether this historical term is a despicable misnomer. Fortunately, the recently founded Hidradenitis Suppurativa Foundation (HSF; http://www.hs-foundation.org), to which EXP DERMATOL serves as home journal, has broken with this unproductive tradition and has encouraged publication of the current CONTROVERSIES feature. This is exclusively devoted to discussing the pathobiology of this chronic neutrophilic folliculitis of unknown origin. Although traces of terminological bickering remain visible, it does the HS experts in our virtual debate room credit that they engage in a constructive and comprehensive dissection of potential pathogenesis pathways that may culminate in the clinical picture we know under the competing terms HS or acne inversa. These experts sketch more often complementary than mutually exclusive pathogenesis scenarios, and the outlines of a conceivable consensus on the many open pathobiology questions begin to emerge in these CONTROVERSIES. Hopefully, this heralds a welcome new tradition: to get to the molecular heart of HS pathogenesis, which can only be achieved by a renaissance of solid basic HS research, as the key to developing more effective HS therapy.
Collapse
|
16
|
Ralf Paus L, Kurzen H, Kurokawa I, Jemec GBE, Emtestam L, Sellheyer K, Giamarellos-Bourboulis EJ, Nagy I, Bechara FG, Sartorius K, Lapins J, Krahl D, Altmeyer P, Revuz J, Zouboulis CC. What causes hidradenitis suppurativa? Exp Dermatol 2008. [DOI: 10.1111/j.1600-0625.2008.00712.x] [Citation(s) in RCA: 93] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
17
|
Sartorius K, Lapins J, Emtestam L, Jemec GBE. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol 2003; 149:211-3. [PMID: 12890229 DOI: 10.1046/j.1365-2133.2003.05390.x] [Citation(s) in RCA: 182] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|